Ushaq (Dorema ammoniacum D. Don) is a well known and potent herbal drug used in various Traditional Medicines for its various beneficial effects in different ailment and diseases. It is commonly known as Gum Ammoniac. It Consists of oleogum resin obtained by exudation from the stem of the flowering and fruiting plant of Dorema ammoniacum D. Don The genus Dorema D. Don comprises 12 species and belongs to Apiaceae (alt. Umbelliferae) family, Dorema ammoniacum D. Don is one of them. It is used in Iranian, Indian and Western Medicine and is listed in the British pharmacopoeia as an antispasmodic and expectorant. The mentioned plant is utilized in the factories producing of glues and cosmetic industry. In Unani Medicine it is used as a potent drug for various ailments as mentioned by Avicenna and Razi in their treatises. This review article discusses the pharmacognosy, phytotherapy, phytochemical and biological studies of Dorema ammoniacum D. Don along with comprehensive review of based on Unani Medicine as well as recent scientific reports.
Background: Dyslipidemia is a significant modifiable risk factor for cardiovascular disease. In type 2 diabetes mellitus (T2DM) patients, elevated low-density lipoprotein cholesterol (LDL-C) levels were associated with an increased risk of ischemic stroke and an increased risk of cardiovascular mortality independent of LDL-C levels. The nutritional needs of the body have been met based on demand, and pharmacotherapy has been avoided to protect the body from any side effects or adverse effects. Methods: This paper is a case study of patient with high lipid profile level. Patient recommended opting Dieto-therapy with modulation in dietary habits for one month with fortnightly follow up for routine check-up. Results: After one month of changing his diet pattern in terms of quality and quantity, his lipid profile started to improve. Conclusions: It is fair to conclude that the concept of dieto-therapy in UMS has a solid base for confirming safe and effective in the management of dyslipidemia.
Type 2 diabetes mellitus (DM) is a chronic metabolic disorder in which prevalence has been increasing steadily all over the world. As a result of this trend, it is fast becoming an epidemic in some countries of the world with the number of people affected expected to double in the next decade due to increase in ageing population, thereby adding to the already existing burden for healthcare providers, especially in poorly developed countries. Worldwide, people are less physically active and this has become a leading risk factor for ill health as millions of lives are lost per year due to physical inactivity which leads to a host of disorders and DM is one of the four major NCDs (Cancer, Diabetes, Chronic respiratory and Cardiovascular diseases) which account for most of the disease burden and premature mortality in the European Region. The WHO has projected that diabetes will be the 7th cause of death by 2030. A patient 34years-old Muslim woman was screened as diabetis mellitus. Patient attended National institute of Unani medicine with complain of Polyuria, polyphagia and burning sensation in a feet. A single drug was used in powdered form for 60 days. The results was assessed after taking unani drug suggested reduction in serum FBS and PPBS level in 60 days. In this case report, we suggested a significant result of Safoofe Habbul Aas for Type 2 diabetes mellitus (DM). By this study, this single unani drug can be used as boon choice therapy for Type 2 diabetes mellitus (DM).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.